Hawkins James B's Form 4 filing
Iradimed Corp (IRMD) · filed Nov 10, 2021
- Accession no.
- 0000898432-21-000723
- Filed
- Nov 10, 2021
- Trade date
- Nov 5-9, 2021
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $626.5K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hawkins James BCIK 0000898243 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2021 | Common Stock | AGrant or awardAcquired | +5,501 | $1.48F1 | +$8,141.48 | 22,769 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −5,501 | $38.25F2 | −$210,413.25 | 17,268 | Direct | |
| Nov 8, 2021 | Common Stock | AGrant or awardAcquired | +9,479 | $1.48F1 | +$14,028.92 | 26,747 | Direct | |
| Nov 8, 2021 | Common Stock | SSaleDisposed | −9,479 | $38.98F3 | −$369,491.42 | 17,268 | Direct | |
| Nov 9, 2021 | Common Stock | AGrant or awardAcquired | +1,234 | $1.48F1 | +$1,826.32 | 18,502 | Direct | |
| Nov 9, 2021 | Common Stock | SSaleDisposed | −1,234 | $37.75 | −$46,583.5 | 17,268 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2021 | Common Stock | MOption exerciseDisposed | −5,501 | $0.00 | $0 | 100,713 | Direct | |
| Nov 8, 2021 | Common Stock | MOption exerciseDisposed | −9,479 | $0.00 | $0 | 91,234 | Direct | |
| Nov 9, 2021 | Common Stock | MOption exerciseDisposed | −1,234 | $0.00 | $0 | 90,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
Referenced by the price of 3 transactions in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $38.25 to $38.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $38.60 to $39.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.